Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis. (Q50996852)

26 March 2018

title

Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis. (English)

1 reference

26 March 2018

author name string

S A Kozin

1

1 reference

26 March 2018

I B Cheglakov

2

1 reference

26 March 2018

A A Ovsepyan

3

1 reference

26 March 2018

G B Telegin

4

1 reference

26 March 2018

P O Tsvetkov

5

1 reference

26 March 2018

A V Lisitsa

6

1 reference

26 March 2018

A A Makarov

7

1 reference

26 March 2018

publication date

14 May 2013

1 reference

26 March 2018

published in

Neurotoxicity Research

1 reference

26 March 2018

volume

24

1 reference

26 March 2018

issue

3

1 reference

26 March 2018

page(s)

370-376

1 reference

26 March 2018

Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta1-42 amyloid peptide and its isoaspartyl isomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Alzheimer's disease: the challenge of the second century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

De novo induction of amyloid-β deposition in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Cell biology. A unifying role for prions in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Isoaspartate formation and neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Biological significance of isoaspartate and its repair system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Purified and synthetic Alzheimer's amyloid beta (Aβ) prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Retro-orbital injections in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Capabilities of MS for Analytical Quantitative Determination of the Ratio of α- and βAsp7 Isoforms of the Amyloid-β Peptide in Binary Mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9399-Y

Evidence for the experimental transmission of cerebral beta-amyloidosis to primates

21 January 2018

1 reference

12 December 2020

Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice.

1 reference

12 December 2020

Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

1 reference

12 December 2020

Very long term studies of the seeding of beta-amyloidosis in primates

1 reference

12 December 2020

Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice.

1 reference

12 December 2020

Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

1 reference

12 December 2020

Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers

1 reference

12 December 2020

[Effect of isomerization of aspartate-7 on the binding of copper (II) ion by the beta-amyloid peptide].

1 reference

12 December 2020

10.1007/S12640-013-9399-Y

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018